BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 12700302)

  • 1. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis.
    Church AJ; Dale RC; Lees AJ; Giovannoni G; Robertson MM
    J Neurol Neurosurg Psychiatry; 2003 May; 74(5):602-7. PubMed ID: 12700302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunobiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward.
    Murphy TK; Kurlan R; Leckman J
    J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):317-31. PubMed ID: 20807070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-basal ganglia antibodies: a possible diagnostic utility in idiopathic movement disorders?
    Church AJ; Dale RC; Giovannoni G
    Arch Dis Child; 2004 Jul; 89(7):611-4. PubMed ID: 15210488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of anti-brain antibodies in children with obsessive-compulsive disorder.
    Dale RC; Heyman I; Giovannoni G; Church AW
    Br J Psychiatry; 2005 Oct; 187():314-9. PubMed ID: 16199788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea.
    Church AJ; Cardoso F; Dale RC; Lees AJ; Thompson EJ; Giovannoni G
    Neurology; 2002 Jul; 59(2):227-31. PubMed ID: 12136062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-basal ganglia antibody].
    Hayashi M
    Brain Nerve; 2013 Apr; 65(4):377-84. PubMed ID: 23568985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome?
    Murphy TK; Goodman WK; Fudge MW; Williams RC; Ayoub EM; Dalal M; Lewis MH; Zabriskie JB
    Am J Psychiatry; 1997 Mar; 154(3):402-7. PubMed ID: 9054790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On defining Sydenham's chorea: where do we draw the line?
    Murphy TK; Goodman WK; Ayoub EM; Voeller KK
    Biol Psychiatry; 2000 May; 47(10):851-7. PubMed ID: 10807957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.
    Dale RC; Merheb V; Pillai S; Wang D; Cantrill L; Murphy TK; Ben-Pazi H; Varadkar S; Aumann TD; Horne MK; Church AJ; Fath T; Brilot F
    Brain; 2012 Nov; 135(Pt 11):3453-68. PubMed ID: 23065479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). A report of two cases].
    Bryńska A; Wolańczyk T
    Psychiatr Pol; 2004; 38(1):105-23. PubMed ID: 15042736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble adhesion molecules in Gilles de la Tourette's syndrome.
    Martino D; Church AJ; Defazio G; Dale RC; Quinn NP; Robertson MM; Livrea P; Orth M; Giovannoni G
    J Neurol Sci; 2005 Jul; 234(1-2):79-85. PubMed ID: 15941572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibasal ganglia antibodies and their relevance to movement disorders.
    Martino D; Giovannoni G
    Curr Opin Neurol; 2004 Aug; 17(4):425-32. PubMed ID: 15247537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies.
    Dale RC; Church AJ; Cardoso F; Goddard E; Cox TC; Chong WK; Williams A; Klein NJ; Neville BG; Thompson EJ; Giovannoni G
    Ann Neurol; 2001 Nov; 50(5):588-95. PubMed ID: 11706964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-basal ganglia antibodies in PANDAS.
    Singer HS; Loiselle CR; Lee O; Minzer K; Swedo S; Grus FH
    Mov Disord; 2004 Apr; 19(4):406-15. PubMed ID: 15077238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette's syndrome, Sydenham's chorea, and autoimmune disorders.
    Morshed SA; Parveen S; Leckman JF; Mercadante MT; Bittencourt Kiss MH; Miguel EC; Arman A; Yazgan Y; Fujii T; Paul S; Peterson BS; Zhang H; King RA; Scahill L; Lombroso PJ
    Biol Psychiatry; 2001 Oct; 50(8):566-77. PubMed ID: 11690591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of anti-basal ganglia antibodies in adult obsessive-compulsive disorder: cross-sectional study.
    Nicholson TR; Ferdinando S; Krishnaiah RB; Anhoury S; Lennox BR; Mataix-Cols D; Cleare A; Veale DM; Drummond LM; Fineberg NA; Church AJ; Giovannoni G; Heyman I
    Br J Psychiatry; 2012 May; 200(5):381-6. PubMed ID: 22282431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary study of the frequency of anti-basal ganglia antibodies and streptococcal infection in attention deficit/hyperactivity disorder.
    Sanchez-Carpintero R; Albesa SA; Crespo N; Villoslada P; Narbona J
    J Neurol; 2009 Jul; 256(7):1103-8. PubMed ID: 19288046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity.
    Dale RC; Church AJ; Surtees RA; Lees AJ; Adcock JE; Harding B; Neville BG; Giovannoni G
    Brain; 2004 Jan; 127(Pt 1):21-33. PubMed ID: 14570817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dystonic syndrome associated with anti-basal ganglia antibodies.
    Edwards MJ; Dale RC; Church AJ; Giovannoni G; Bhatia KP
    J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):914-6. PubMed ID: 15146015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late recurrences of Sydenham's chorea are not associated with anti-basal ganglia antibodies.
    Harrison NA; Church A; Nisbet A; Rudge P; Giovannoni G
    J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1478-9. PubMed ID: 15377702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.